Chemogen

Welcome to Chemogen

Chemogen is an emerging biotechnology company focused on the development and commercialization of a novel and proprietary platform technology for the rapid diagnosis of infectious diseases. The initial application of this technology is in the area of tuberculosis (“TB”), the world’s deadliest infectious disease.

Beyond TB, Chemogen’s technology provides additional product opportunities to address global health threats in other infectious disease areas with significant market opportunities, including homeland security screening applications.

Our Vision

To become and be recognized as a leader in the battle against infectious diseases by delivering novel and high quality diagnostic products to the world.